Bibliografia:
| ARMANDO, R. G. et al. New drugs are not enough drug repositioning in oncology: An update. Intern. J. Oncol., 56, 651-684, 2020<br />SAITO RF, LANA MVG, MEDRANO RFV, CHAMMAS R. Fundamentos de Oncologia Molecular. Editora Atheneu, São Paulo. 2015.<br />HANAHAN, D., WEINBERG, R. A. The Hallmarks of Cancer: the next generation. Cell, 144: 646-674, 2011.<br />MOSES, C. GARCIA-BLOJ, B. HARVEY, A. BLANCAFORT, P. Hallmarks of cancer: The CRISPR Generation. European Journal of Cancer 93 (2018).<br />O`CONNOR et al., Cancer stem cells: A contentious hypothesis now moving forward. Cancer Letters 344 (2014) 180187.<br />COOPER, G.M. The cell: A molecular approach. 8° edition. Sinauer Associates. 2018. 816p<br />HOFF, P. M. G. Tratado de Oncologia. Vol. 1 e 2. Porto Alegre: Atheneu, 2012.<br />CHAU, C. H. et al. Antibodydrug conjugates for cancer. Lancet, 394, 793-804, 2019. <br />HANAHAN. D, COUSSENS L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 21(3):309-22, 2012.<br />WEINBERG, R. A. The Biology of Cancer. 2. ed. Garland Science Publishing: New York and London, 2013.<br /><br />Artigos científicos da base de dados Pubmed dos últimos 10 anos. |